Unimark Remedies
About Unimark Remedies
About Unimark Remedies
Founded in
1982 (42 yrs old) Ownership
Private
India Employee count
201-500 Global Employee count
501-1k Headquarters
Mumbai, India
Office Locations
Mumbai, India
CEO Suggest Founders Suggest Type of Company Suggest Nature of Business Suggest Company Email ID Suggest Company Contact no. Suggest Social Media Presence Suggest Website
unimarkremedies.com
• Established in 1993, Unimark Remedies Ltd. (“Unimark” or the “Company”) is engaged in the manufacturing and marketing of niche APIs, Intermediates and Injectables.
• Its key products include Lisinopril, Imipenem, Nalidixic acid, Flecanide, Montelukast, Meropenem, etc.
• The Company had market reach to supply its products to over 400 customers across 65 countries including major global pharma players.
• It has strong product development and manufacturing capabilities and has successfully filed 52 DMFs (API & Intermediates).
• It has also filed 15 ANDAs out of which 2 have already been approved and commercialized. Additional 9 are in various stages of development.
• The Company has also filed dossiers for Carbapenem with US and EU regulatory authorities and is expecting approval.
Primary Industry
i
Primary industry refers to the industry from which a company drives
its maximum revenue.
Pharma
(Healthcare)
Report error
